Axon Enterprise Inc. (AXON) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Axon Enterprise Inc. (AXON) has a cash flow conversion efficiency ratio of 0.005x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($20.08 Million) by net assets ($3.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Axon Enterprise Inc. (AXON) total market value for the company's overall valuation and market capitalisation.
Axon Enterprise Inc. - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Axon Enterprise Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Axon Enterprise Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Axon Enterprise Inc. ranked by their cash flow conversion efficiency. Explore earnings quality score of Axon Enterprise Inc. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CTBC Financial Holding Co Ltd Pref
TW:2891B
|
-0.031x |
|
EQT AB (publ)
ST:EQT
|
0.035x |
|
FORTESCUE MET.GR.SP.ADR 2
F:FVJA
|
N/A |
|
3I GROUP PLC ADR 1/2
F:IGQ
|
N/A |
|
RWE AG
XETRA:RWE
|
0.060x |
|
Yum! Brands Inc
NYSE:YUM
|
-0.057x |
|
DEUTSCHE BOERSE ADR 1/10
F:63DA
|
N/A |
|
Microchip Technology Inc
NASDAQ:MCHP
|
0.040x |
Annual Cash Flow Conversion Efficiency for Axon Enterprise Inc. (2000–2025)
The table below shows the annual cash flow conversion efficiency of Axon Enterprise Inc. from 2000 to 2025. View AXON stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.24 Billion | $211.34 Million | 0.065x | -62.85% |
| 2024-12-31 | $2.33 Billion | $408.31 Million | 0.175x | +49.76% |
| 2023-12-31 | $1.62 Billion | $189.26 Million | 0.117x | -36.87% |
| 2022-12-31 | $1.27 Billion | $235.36 Million | 0.186x | +56.17% |
| 2021-12-31 | $1.05 Billion | $124.49 Million | 0.119x | +201.42% |
| 2020-12-31 | $976.25 Million | $38.48 Million | 0.039x | -67.38% |
| 2019-12-31 | $543.50 Million | $65.67 Million | 0.121x | -11.59% |
| 2018-12-31 | $467.32 Million | $63.88 Million | 0.137x | +23.78% |
| 2017-12-31 | $167.44 Million | $18.49 Million | 0.110x | -7.05% |
| 2016-12-31 | $150.89 Million | $17.93 Million | 0.119x | -59.84% |
| 2015-12-31 | $157.00 Million | $46.45 Million | 0.296x | +7.79% |
| 2014-12-31 | $129.11 Million | $35.43 Million | 0.274x | -6.99% |
| 2013-12-31 | $109.89 Million | $32.43 Million | 0.295x | -2.87% |
| 2012-12-31 | $87.29 Million | $26.52 Million | 0.304x | +44.09% |
| 2011-12-31 | $82.17 Million | $17.32 Million | 0.211x | +3288.53% |
| 2010-12-31 | $117.56 Million | $731.52K | 0.006x | -92.78% |
| 2009-12-31 | $117.70 Million | $10.15 Million | 0.086x | +19.52% |
| 2008-12-31 | $112.53 Million | $8.12 Million | 0.072x | -37.49% |
| 2007-12-31 | $120.64 Million | $13.92 Million | 0.115x | +53.22% |
| 2006-12-31 | $99.33 Million | $7.48 Million | 0.075x | +632.75% |
| 2005-12-31 | $103.87 Million | $1.07 Million | 0.010x | -96.71% |
| 2004-12-31 | $97.12 Million | $30.30 Million | 0.312x | +95.99% |
| 2003-12-31 | $27.43 Million | $4.37 Million | 0.159x | +214.74% |
| 2002-12-31 | $6.01 Million | $-834.51K | -0.139x | -38.24% |
| 2001-12-31 | $5.53 Million | $-554.89K | -0.100x | -4188.19% |
| 2000-12-31 | $-3.62 Million | $8.47K | -0.002x | -- |
About Axon Enterprise Inc.
Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Services, and Connected Devices. The Software and Services segment develops, manufactures, and sells cloud-based software-as-a-service solutions to capture, store, manage, share, and analyze video and other digital evidence. This segment al… Read more